semaglutide 5 mg vials Fundamentals Explained
The demo realized equally its primary endpoints, with semaglutide 2.four mg demonstrating statistically considerable and remarkable enhancements in liver fibrosis without any worsening of steatohepatitis, along with resolution of steatohepatitis with no worsening of liver fibrosis in those with MASH as compared to placebo.1The subsequent really ser